Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
February 19, 2024
Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
August 17, 2021
Related Post
-
-
Endexx Corporation Announces Strategic Shift in Auditor Services to Bolster Growth and Transparency
February 16, 2024
-
Biotricity Advances Towards Breakeven Milestone – Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024
February 14, 2024
-
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
February 14, 2024